- The Influence of Cisplatin Dose upon Survival in Concurrent Chemoradiotherapy of Locally Advanced Cervical Carcinoma with Weekly Cisplatin2008 | First Faculty of Medicine
- Concurrent chemoradiotherapy of inoperable non-small cell lung cancer – prognostic factors and causes of failure in a 1996–2008 group of patients2012 | First Faculty of Medicine
- Chemotherapy Intensity Importance in Concurrent Chemoradiotherapy of Locally Advanced Cervical Cancer2006 | Publication without faculty affiliation
- Chemotherapy Intensity Importance in Concurrent Chemoradiotherapy of Locally Advanced Cervical Cancer2006 | First Faculty of Medicine
- What we have learned from our approach to concurrent chemoradiotherapy in cervical cancer2002 | First Faculty of Medicine
- The Influence of Cisplatin Dose upon Survival in Concurrent Chemoradiotherapy of Locally Advanced Cervical Carcinoma with Weekly Cisplatin +12008 | Faculty of Medicine in Hradec Králové
- Chemotherapy Intensity Importance in Concurrent Chemoradiotherapy of Locally Advanced Cervical Cancer +12006 | Faculty of Medicine in Hradec Králové
- Prognostic factors on oesophageal cancer patients treated by preoperative concurrent chemoradiotherapy and surgeryPublication without faculty affiliation
- Prediction of treatment response in patients with locally advanced cervical cancer using midtreatment PET/MRI during concurrent chemoradiotherapy2021 | Faculty of Medicine in Pilsen
- Impact of early concurrent chemoradiotherapy and prophylactic cranial irradiation in limited disease small cell lung cancer treatment - experience since 2000Publication without faculty affiliation
- Serum Adiponectin Relates to Shortened Overall Survival in Men with Squamous Cell Esophageal Cancer Treated with Preoperative Concurrent Chemoradiotherapy: A Pilot Study2014 | First Faculty of Medicine
- Reply to: Prediction of treatment response in patients with locally advanced cervical cancer using midtreatment PET/MRI during concurrent chemoradiotherapy. In regard to Vojtisek et al2021 | Faculty of Medicine in Pilsen
- Chemoradiotherapy in the treatment of cervical cancer - a single institution retrospective review2022 | First Faculty of Medicine
- Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study2004 | First Faculty of Medicine, Faculty of Physical Education and Sport, Third Faculty of Medicine
- Impact of comorbidities and lifestyle factors on treatment outcomes in patients with laryngeal cancer - a single institution retrospective review2022 | First Faculty of Medicine
- Impact of comorbidity scores and lifestyle factors in curative radiotherapy in laryngeal cancer2023 | First Faculty of Medicine
- Prognostic factors in a group of patients with limited-disease small cell lung cancer2012 | First Faculty of Medicine
- Treatment of Cervical Cancer with Paraaortic Lymph Node Involvement - Retrospective Review2020 | First Faculty of Medicine
- Postoperative Adjuvant Lapatinib and Concurrent Chemoradiotherapy Followed by Maintenance Lapatinib Monotherapy in High-Risk Patients With Resected Squamous Cell Carcinoma of the Head and Neck: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study2015 | First Faculty of Medicine
- Chemotherapy and biological targeted therapy in squamous cell carcinoma of the head and neck2012 | First Faculty of Medicine
- Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial2019 | Publication without faculty affiliation
- Positron Emission Tomography-Guided Bone Marrow-Sparing Radiation Therapy for Locoregionally Advanced Cervix Cancer: Final Results From the INTERTECC Phase II/III Trial2022 | Publication without faculty affiliation
- Concurrent Versus Sequential Radiochemotherapy With Vinorelbine Plus Cisplatin (V-P) In Locally Advanced Non-small Cell Lung cancer. A randomized phase II study - long-term follow-up data2003 | First Faculty of Medicine
- Concurrent Versus Sequential Radiochemotherapy With Vinorelbine Plus Cisplatin (V-P) In Locally Advanced Non-small Cell Lung cancer. A randomized phase II study - long-term follow-up data2003 | Faculty of Physical Education and Sport
- Locally advanced esophageal cancer – multidisciplinar management – personal experience2012 | First Faculty of Medicine
- Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial2014 | Third Faculty of Medicine
- Comparison of Hematologic Toxicity and Bone Marrow Compensatory Response in Head and Neck vs. Cervical Cancer Patients Undergoing Chemoradiotherapy2020 | Publication without faculty affiliation